ALEC: Alector Inc. Price to Earnings Adjusted for Growth Rate
Alector's San Francisco base is supported by high-tech laboratories with independent power supplies. Tracking the Valuation/Growth Balance indicator on GURU.Markets, we note that the 0.00 ratio indicates a growth P/E ratio. High costs for FDA testing and patents create barriers for competitors, while the partnership with GSK and the development of AL001 fuel the company's potential.
Metric breakdowns and analytics for Alector, Inc. (ALEC)
- current price and projected stock value:
- market capitalization information:
- shareholders' equity book value data:
- debt obligations and liquidity statistics:
- business earnings and investment ratios data:
ALEC - Net Profit|Future Profit Alector, Inc.|ALEC - Price to Earnings Ratio|Market Cap to Projected Earnings alector.com|ALEC - PEG Multiple|EV/EBITDA Multiple Alector Therapeutics|ALEC - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months Alector|ALEC - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months alector.com|ALEC - Earnings growth in current year|Expected earnings per share growth for next year Alector, Inc.
Summary company analytics:Alector Inc., ALEC
Searching for undervalued assets requires comparing market value with earnings growth, where a value below one signals growth potential. This PEG ratio measures the business expansion efficiency of Alector, Inc. (ALEC), considering that geopolitical conflicts and sanctions are slowing clinical trials for neuro-drugs, which makes monitoring this indicator critical for verifying fundamental value.
Competing companies
Price/Earnings to Growth Ratio BIIB (Biogen Inc)|PEG Multiple NBIX (Neurocrine Biosciences Inc)|Regencell Corp (RGC) - Price to Earnings Adjusted for Growth Rate|Axsome Therapeutics - PEG Multiple|acadia-pharm.com (ACAD) - Price/Earnings to Growth Multiple|XENE (Xenon) - Price/Earnings to Growth Multiple|VKTX: Company Value to Earnings Growth Ratio|Price/Earnings to Growth Ratio Supernus Pharma|Price to Earnings Adjusted for Growth Rate Catalyst Corp CPRX|Price/Earnings to Growth Ratio Denali Therapeutics (DNLI)|HRMY (harmonybiosciences.com) - Growth-Adjusted Payback Ratio|Biohaven - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio AMLX|Trevi Pharma - PEG Multiple|Growth-Adjusted Market Cap to Net Income Praxis Corp PRAX|Anavex Life Sciences (AVXL) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio CBLL|PRTA (Prothena Corporation plc) - PEG Multiple|Price/Earnings to Growth Multiple Annexon Biosciences (ANNX)|Price/Earnings to Growth Multiple OMER (Omeros Corporation)|Growth-Adjusted Market Cap to Net Income Neurogene Therapeutics|PEG Multiple ACIU (AC Immune)|PEG Multiple voyagertherapeutics.com VYGR|NMRA - Price/Earnings to Growth Ratio|SCLX: Price/Earnings to Growth Ratio|TVGN: PEG Multiple|Price to Earnings Adjusted for Growth Rate Alpha Cognition Inc. (ACOG)|CGTX (Cognition Therapeutics) - PEG Multiple|Price/Earnings to Growth Multiple inhibikase.com (IKT)|Price/Earnings to Growth Ratio Cassava Sciences (SAVA)|assertiotx.com - Growth-Adjusted P/E Ratio|PEG Multiple COYA (Coya Therapeutics)|VistaGen Therapeutics, Inc. (VTGN) - Price to Earnings Adjusted for Growth Rate|OVID: Price/Earnings to Growth Multiple|ABOS - PEG Multiple|CervoMed (CRVO) - Price/Earnings to Growth Ratio|Alterity Therapeutics Limited - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Clene Inc|Price to Earnings Adjusted for Growth Rate PepGen Corp PEPG|PEG Multiple JUNS|PEG Multiple relmada.com (RLMD)|Price/Earnings to Growth Ratio Annovis Bio ANVS|Grace Therapeutics Inc - Price/Earnings to Growth Ratio|Firefly Neuroscience Inc - PEG Multiple|Price to Earnings Adjusted for Growth Rate Klotho Neurosciences Inc|NRSN: PEG Multiple|Price/Earnings to Growth Multiple revivapharma.com|Price/Earnings to Growth Multiple MTVA|NRXS (NeurAxis Inc.) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Ratio Helius Medical (HSDT)|PASG - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Neuphoria Therapeutics NEUP|Growth-Adjusted Payback Ratio NERV|ATHA: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio ADXN (Addex Therapeutics Ltd.)|ALZN: PEG Multiple|CYCN - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Protagenic Therapeutics Inc.|Growth-Adjusted P/E Ratio KTTA (Pasithea)|PEG Multiple CRGT|Price/Earnings to Growth Multiple Avenue Therapeutics Inc. ATXI|Brainstorm Cell Therapeutics, Inc. - Price/Earnings to Growth Multiple|Growth-Adjusted Market Cap to Net Income Cara Therapeutics Inc (CARA)|Chromocell Therapeutics - PEG Multiple|ELYM - PEG Multiple|intracellulartherapies.com (ITCI) - Price/Earnings to Growth Ratio|LBPH (Longboard Pharmaceuticals Inc) - Price/Earnings to Growth Ratio|MRNS (Marinus) - PEG Multiple|Price to Earnings Adjusted for Growth Rate NKGen Biotech Corp NKGN|PEG Multiple NRBO|Price/Earnings to Growth Multiple sagerx.com SAGE|Price/Earnings to Growth Ratio Synaptogenix SNPX|TRVN: Growth-Adjusted P/E Ratio|Vigil Neuro - PEG Multiple|Price to Earnings Adjusted for Growth Rate Anew Medical Inc.|CERE (Cerevel Therapeutics) - Price/Earnings to Growth Multiple
